Armour CL - Search Results

1

An evaluation of prostaglandin E2 vaginal gel use in practice.

Taylor SJ, Peat JK, Armour CL. Taylor SJ, et al. Among authors: armour cl. J Clin Pharm Ther. 1999 Aug;24(4):303-10. doi: 10.1046/j.1365-2710.1999.00229.x. J Clin Pharm Ther. 1999. PMID: 10475989

2

Cost implications in the management of induction of labour.

Taylor SJ, Armour CL. Taylor SJ, et al. Among authors: armour cl. Pharmacoeconomics. 1997 Nov;12(5):547-54. doi: 10.2165/00019053-199712050-00005. Pharmacoeconomics. 1997. PMID: 10174321 Review.

3

Measurement of consumer preference for treatments used to induce labour: a willingness-to-pay approach.

Taylor SJ, Armour CL. Taylor SJ, et al. Among authors: armour cl. Health Expect. 2000 Sep;3(3):203-216. doi: 10.1046/j.1369-6513.2000.00098.x. Health Expect. 2000. PMID: 11281930 Free PMC article.

4

Cost-benefit analysis of a Haemophilus influenzae type b meningitis prevention programme in The Philippines.

Limcangco MR, Armour CL, Salole EG, Taylor SJ. Limcangco MR, et al. Among authors: armour cl. Pharmacoeconomics. 2001;19(4):391-400. doi: 10.2165/00019053-200119040-00006. Pharmacoeconomics. 2001. PMID: 11383755 Review.

5

Acceptability of willingness to pay techniques to consumers.

Taylor SJ, Armour CL. Taylor SJ, et al. Among authors: armour cl. Health Expect. 2002 Dec;5(4):341-56. doi: 10.1046/j.1369-6513.2002.00201.x. Health Expect. 2002. PMID: 12460223 Free PMC article.

6

Consumer preference for dinoprostone vaginal gel using stated preference discrete choice modelling.

Taylor S, Armour C. Taylor S, et al. Pharmacoeconomics. 2003;21(10):721-35. doi: 10.2165/00019053-200321100-00004. Pharmacoeconomics. 2003. PMID: 12828494

7

Implementation and evaluation of Australian pharmacists' diabetes care services.

Armour CL, Taylor SJ, Hourihan F, Smith C, Krass I. Armour CL, et al. J Am Pharm Assoc (2003). 2004 Jul-Aug;44(4):455-66. doi: 10.1331/1544345041475625. J Am Pharm Assoc (2003). 2004. PMID: 15372866

8

Impact on medication use and adherence of Australian pharmacists' diabetes care services.

Krass I, Taylor SJ, Smith C, Armour CL. Krass I, et al. Among authors: armour cl. J Am Pharm Assoc (2003). 2005 Jan-Feb;45(1):33-40. doi: 10.1331/1544345052843093. J Am Pharm Assoc (2003). 2005. PMID: 15730115

9

Innovative asthma health promotion by rural community pharmacists: a feasibility study.

Kritikos V, Saini B, Bosnic-Anticevich SZ, Krass I, Shah S, Taylor S, Armour C. Kritikos V, et al. Health Promot J Austr. 2005 Apr;16(1):69-73. doi: 10.1071/he05069. Health Promot J Austr. 2005. PMID: 16389935

10

Pharmacy diabetes care program: analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy.

Krass I, Mitchell B, Clarke P, Brillant M, Dienaar R, Hughes J, Lau P, Peterson G, Stewart K, Taylor S, Wilkinson J, Armour C. Krass I, et al. Diabetes Res Clin Pract. 2007 Mar;75(3):339-47. doi: 10.1016/j.diabres.2006.06.022. Epub 2006 Aug 1. Diabetes Res Clin Pract. 2007. PMID: 16884811

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters